1
CD19 CARvac T Cells for Patients With Relapsed / Refractory B Cell Malignancies
Condition(s):B Cell Lymphoma; B Cell LeukemiaLast Updated:November 12, 2019Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.